HRT Financial’s Daseke, Inc. Common Stock DSKE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-119,697
| Closed | -$993K | – | 3380 |
|
|
2024
Q1 | $993K | Buy |
+119,697
| New | +$981K | 0.01% | 889 |
|
|
2023
Q3 | – | Sell |
-41,130
| Closed | -$293K | – | 3318 |
|
|
2023
Q2 | $293K | Buy |
+41,130
| New | +$289K | ﹤0.01% | 1644 |
|
|
2023
Q1 | – | Sell |
-15,773
| Closed | -$89K | – | 3391 |
|
|
2022
Q4 | $89K | Buy |
15,773
+4,047
| +35% | +$23.9K | ﹤0.01% | 2083 |
|
|
2022
Q3 | $63K | Buy |
+11,726
| New | +$75.4K | ﹤0.01% | 2424 |
|
|
2022
Q1 | – | Sell |
-22,914
| Closed | -$230K | – | 4060 |
|
|
2021
Q4 | $230K | Sell |
22,914
-1,794
| -7% | -$17.6K | ﹤0.01% | 2446 |
|
|
2021
Q3 | $227K | Buy |
+24,708
| New | +$206K | ﹤0.01% | 2600 |
|
|
2021
Q1 | – | Sell |
-43,532
| Closed | -$252K | – | 3278 |
|
|
2020
Q4 | $252K | Buy |
+43,532
| New | +$278K | 0.01% | 1392 |
|
|
2020
Q1 | – | Sell |
-22,335
| Closed | -$70K | – | 1463 |
|
|
2019
Q4 | $70K | Buy |
+22,335
| New | +$65.4K | ﹤0.01% | 1054 |
|
HRT Financial's DSKE Position: Q2 2024 in Review
HRT Financial sold out of Daseke, Inc. Common Stock (DSKE) in Q2 2024, closing a stake of 119,697 shares — an estimated $993K sold.
HRT Financial first reported a position in DSKE in Q4 2019 and held it in 8 quarters. The position peaked at $993K in Q1 2024. 0 funds tracked by Wall St. Rank hold DSKE as of Q2 2024.
- HRT Financial reported no remaining Daseke, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- HRT Financial sold 119,697 Daseke, Inc. Common Stock shares in Q2 2024, an estimated $993K.
- HRT Financial first reported a position in Daseke, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
- HRT Financial's Daseke, Inc. Common Stock position peaked at $993K in Q1 2024.
- 0 funds tracked by Wall St. Rank held Daseke, Inc. Common Stock as of Q2 2024.
Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.